Medicare Enrolled
Dr. Clifford Garvin, M.D.
Optician · Denison, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Garvin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garvin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Garvin
Dr. Clifford Garvin is an optician specialist in Denison, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Garvin performed 5,625 Medicare services across 1,758 unique beneficiaries.
Between the years covered by Open Payments, Dr. Garvin received a total of $5,596 from 54 pharmaceutical and/or device companies across 364 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Garvin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in TX
$5,596 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,625
Medicare services
Top 13% in TX for optician
1,758
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~296 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
3,836 | $53 | $152 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
558 | $55 | $110 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
279 | $85 | $150 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
209 | $131 | $308 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
191 | $116 | $246 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
156 | $158 | $165 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
95 | $4 | $16 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
92 | $5 | $5 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
39 | $10 | $30 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
28 | $33 | $40 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
28 | $24 | $25 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
23 | $52 | $150 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
21 | $124 | $151 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
15 | $36 | $80 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
15 | $4 | $35 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
14 | $10 | $70 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
14 | $57 | $233 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $35 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,596
Total received (2018-2024)
Avg $799/year across 7 years
Top 25% in TX for optician
54
Companies
364
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,596 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$874
2023
$653
2022
$652
2021
$915
2020
$697
2019
$821
2018
$984
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$895
Janssen Pharmaceuticals, Inc
$480
ABBVIE INC.
$459
Novo Nordisk Inc
$367
GlaxoSmithKline, LLC.
$332
Otsuka America Pharmaceutical, Inc.
$281
Merck Sharp & Dohme Corporation
$256
AstraZeneca Pharmaceuticals LP
$179
Lilly USA, LLC
$168
AbbVie Inc.
$154
ITI, Inc.
$139
Avanir Pharmaceuticals, Inc.
$139
Takeda Pharmaceuticals U.S.A., Inc.
$138
Allergan, Inc.
$116
Astellas Pharma US Inc
$110
Allergan Inc.
$106
Sumitomo Pharma America, Inc.
$88
SANOFI-AVENTIS U.S. LLC
$82
Novartis Pharmaceuticals Corporation
$68
Eisai Inc.
$68
Mylan Specialty L.P.
$66
Phathom Pharmaceuticals, Inc.
$55
Teva Pharmaceuticals USA, Inc.
$54
Kyowa Kirin, Inc.
$51
Corium, LLC
$48
Nestle HealthCare Nutrition Inc.
$44
Biogen, Inc.
$40
Ardelyx, Inc.
$38
Xeris Pharmaceuticals, Inc.
$38
Avion Pharmaceuticals
$35
Abbott Laboratories
$33
SCILEX PHARMACEUTICALS INC.
$33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$31
IDORSIA PHARMACEUTICALS US INC
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Ultragenyx Pharmaceutical Inc.
$30
Lundbeck LLC
$28
UCB, Inc.
$24
NOVARTIS PHARMACEUTICALS CORPORATION
$23
Dexcom, Inc.
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
Bayer Healthcare Pharmaceuticals Inc.
$19
Neurelis, Inc.
$18
Amgen Inc.
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
Exact Sciences Corporation
$17
SK Life Science, Inc.
$16
ACADIA Pharmaceuticals Inc
$15
Sunovion Pharmaceuticals Inc.
$15
Otsuka Pharmaceutical Development & Commercialization, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$14
Sun Pharmaceutical Industries Inc.
$13
Purdue Pharma L.P.
$12
IRONWOOD PHARMACEUTICALS, INC
$11
Top 3 companies account for 32.8% of total payments
Associated products mentioned in payments ›
ADUHELM · AIRSUPRA · ANORO · ANORO ELLIPTA · APTIOM · AREXVY · Adlarity · Austedo XR · BAQSIMI · BELSOMRA · BREZTRI · BYSTOLIC · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · Dhivy · ELIQUIS · ENTRESTO · FARXIGA · FASENRA · FLECTOR · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GEMTESA · GVOKE PFS · IBSRELA · INVEGA SUSTENNA · INVOKANA · JANUMET · JANUVIA · KAPSPARGO · Kerendia · LINZESS · LYRICA · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · Nuedexta · Otezla · Ozempic · PREMARIN · PREVNAR - 13 · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · Rybelsus · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TZIELD · Tresiba · Trintellix · UBRELVY · UZEDY · VALTOCO · VIAGRA · VOQUEZNA · VRAYLAR · Victoza · Vimpat · Wegovy · XARELTO · XIFAXAN · YUPELRI · ZENPEP · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $99 per 100 Medicare services performed
Geographic Context
Opticians within 10 mi
37
Per 100K population
26.4
County median income
$70,455
Nearest hospital
TEXOMA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Garvin is a clinical cardiology specialist, with above-average Medicare volume (top 13% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Garvin experienced with nursing facility visit, low complexity?
Based on Medicare claims data, Dr. Garvin performed 3,836 nursing facility visit, low complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Garvin receive payments from pharmaceutical companies?
Yes. Dr. Garvin received a total of $5,596 from 54 companies across 364 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garvin's costs compare to other opticians in Denison?
Dr. Garvin's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garvin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Denison
Browse opticians in Denison ranked by procedure volume and transparency data.
Highest volume
Top Opticians in TX
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in TX
Which TX opticians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology